NCT00254423 2026-01-15Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous LeukemiaM.D. Anderson Cancer CenterPhase 2 Completed150 enrolled 10 charts
NCT03654768 2025-12-18Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid LeukemiaSWOG Cancer Research NetworkPhase 2 Active not recruiting81 enrolled 20 charts
NCT04060277 2025-11-14Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantationCity of Hope Medical CenterPhase 2 Active not recruiting7 enrolled 12 charts
NCT00015847 2025-08-22Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaOHSU Knight Cancer InstitutePhase 2 Terminated25 enrolled 8 charts
NCT02506933 2025-08-22Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell TransplantCity of Hope Medical CenterPhase 2 Active not recruiting102 enrolled 10 charts
NCT03333486 2025-07-04Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood CancerRoswell Park Cancer InstitutePhase 2 Terminated31 enrolled 18 charts
NCT00544115 2025-06-10Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersCity of Hope Medical CenterPhase 2 Active not recruiting260 enrolled 13 charts